Premier Alternatives

Zenshine Pharmaceuticals (Nanjing) Group

Nanjing, China · Founded 2018 · In IPO Registration

Developer and provider of innovative antiviral and oncology therapies designed for unmet clinical needs in viral infections, cancer, and inflammatory diseases. Zenshine Pharmaceuticals (Nanjing) Group is based in Nanjing, China and was founded in 2018. Its last reported valuation was $354 million in Jan 2026. It has raised $127 million.

Last reported valuation
$354.4M
Oct 2026
Priced at
—
Total raised
$126.6M
Last round
—
How much has Zenshine Pharmaceuticals (Nanjing) Group raised?
$126.6Macross 0 recorded rounds
Free account
More of Zenshine Pharmaceuticals (Nanjing) Group with a free account
  • ·The complete investor list: 21 names
  • ·Watch Zenshine Pharmaceuticals (Nanjing) Group: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Zenshine Pharmaceuticals (Nanjing) Group investors

21 investors are on record for Zenshine Pharmaceuticals (Nanjing) Group, including China Capital Management, CMG SDIC Fund, Tailong VC and Proxima Ventures (China).

For fundraisers
Raising for a company like Zenshine Pharmaceuticals (Nanjing) Group?

21 investors have backed Zenshine Pharmaceuticals (Nanjing) Group.

See all 21 investors →

Frequently asked about Zenshine Pharmaceuticals (Nanjing) Group

How much has Zenshine Pharmaceuticals (Nanjing) Group raised?
Zenshine Pharmaceuticals (Nanjing) Group has raised $126.6M in total across 0 recorded funding rounds.